hrp0089p2-p249 | Growth & Syndromes P2 | ESPE2018

GrowInform – A Campaign for Early Diagnosis and Treatment of Growth Disorders

Stoycheva Rosica , Iotova Violeta , Galcheva Sonya , Yordanova Galina , Tsochev Kaloyan , Ivanova Antoaneta , Karamfilova Teodora

In 2014 Varna Pediatric Endocrine Society started a program for timely diagnosis and treatment of stature deviations. GPs with 23 058 children under their care were trained and provided with a specialized auxological software to warn them for every stature deviation. From the expected 692 children with short stature (3% of the total), only 33 (0.14%) were sent for further evaluation. Due to the unsatisfactory results we decided to organise a new campaign with the help of media...

hrp0092t13 | Top 20 Poster | ESPE2019

Results from the Implementation of a 2 Year Growth Awareness and Growth Disorders Screening Campaign (GrowInform)

Tsochev Kaloyan , Stoycheva Rosica , Iotova Violeta , Karamfilova Teodora , Markovska Velina , Halvadjian Irina , Galcheva Sonya , Mladenov Vilhelm , Boyadzhiev Veselin , Ivanova Antoaneta

Aim: Evaluation of the results from the campaign GrowInform (2017-2019), a project with the main aim to raise awareness of growth disorders, and secondary aims to facilitate screening for growth deviations in children from areas with no easy access to pediatric endocrinologists, thus achieving earlier diagnosis and treatment.Methods: For 2 years (April 2017 to March 2018), GrowInform acted in 13 cities and towns from Eas...

hrp0084p3-827 | Endocrine Oncology | ESPE2015

The Pathway to the True Diagnosis

Stoycheva Rositca

Case presentation: A 3 year old girl was admitted with the diagnosis of acute interstitial nephritis from the family doctor directly to our tertiary hospital. As an out-patient, the girl was treated with antibiotics with no result. She had polydipsia accompanied by day-time and night-time polyuria and enuresis that developed 2 weeks before admission. During the last year the girl showed increased appetite and escalating weight gain. At admission, her height was +3.5 SDS, weigh...

hrp0084p2-476 | Growth | ESPE2015

One Year Screening Program for Stature Deviations – Strategy and Outcome

Yordanova Galina , Iotova Violeta , Lateva Mina , Galcheva Sonya , Stoycheva Rositsa , Mladenov Vilchelm , Boyadjiev Vesselin , Bazdarska Yulia , Ivanova Antonia

Background: Many children still miss the early recognition of their stature problems due to inefficient screening strategies.Objective and hypotheses: To assess stature deviations referral through recruiting general practitioners (GPs) and providing them with tools for easier anthropometric data assessment and enhanced access to the Paediatric Endocrinologist.Method: Thirty-one general practitioners with a total of 23 058 patients ...

hrp0094p2-317 | Growth and syndromes (to include Turner syndrome) | ESPE2021

Noonan syndrome patients with short stature at a single pediatric endocrinology centre

Deyanova Y. , Iotova V. , Tsochev K. , Stoyanova M. , Stoicheva R. , Mladenov V. , Bazdarska Y. , Galcheva S. , Zenker M. ,

Introduction: Noonan syndrome (NS) is caused by mutations in RAS/MAPK signaling pathway genes. About 70% of the NS patients have short stature, and human recombinant growth hormone (rhGH) is an established yet not fully standardized treatment.Objective: To assess the first 2 years rhGH treatment effectiveness in NS patients at a single centre.Materials and methods: A total of 20 (16 male) NS patien...

hrp0092p1-108 | Pituitary, Neuroendocrinology and Puberty | ESPE2019

Hyperprolactinemia in Children with Juvenile Idiopathic Arthritis

Eremciuc Rodica , Revenco Ninel

Background: Multiple causes of hyperprolactinemia can be identified in some patients with rheumatic diseases. Prolactin maintains cartilage maintenance, osteogenesis, growth, proliferation and apoptosis as well as the release of proinflammatory mediators by immune cells – events that can both induce and prevent rheumatic diseases. The aim of this study is to analyze the serum prolactin level in patients with juvenile idiopathic arthritis (JIA), and their ...

hrp0086p2-p186 | Bone & Mineral Metabolism P2 | ESPE2016

Unclear Origin of Avascular Necrosis – Clinical Case

Revenco Ninel , Eremciuc Rodica , Grin Olesea , Bogonovschi Livia , Foca Silvia

Background: Glucocorticoid (GC) treatment is associated with many unwanted effects but osteoporosis and fractures are the most serious adverse events. Several large case–control studies have shown strong associations between exposure to glucocorticoids and the risk of fractures. By other hand, multiple factors have been associated with avascular necrosis (AVN) in systemic lupus erythematosus (SLE), but it is steroid use that has been...

hrp0082p3-d1-819 | Growth | ESPE2014

Body Composition in GH Deficient Children: Effects of GH Therapy and Comparison Between DXA and Anthropometric Data

Capalbo Donatella , Esposito Andrea , Cerbone Manuela , Rezzuto Martina , Di Pinto Rosita , Mainolfi Ciro , Salerno Mariacarolina

Background: GH deficiency (GHD) in adults has been consistently associated with increased adiposity and decreased lean mass. Data in childhood are still scanty and the most appropriate tools to assess body composition in these children remain to be established.Objective and hypotheses: To evaluate the effects of GHD and GH replacement therapy (GHRT) on body composition in GHD children and make a comparison between DXA and anthropometric measures in evalu...

hrp0094p2-293 | Growth and syndromes (to include Turner syndrome) | ESPE2021

Effects of GH replacement therapy on body composition and muscle health in children and adolescents with GH deficiency: one-year prospective case-control study.

Improda Nicola , Capalbo Donatella , Di Mase Raffaella , Di Pinto Rosita , Alicante Paola , Scalfi Luca , Salerno Mariacarolina ,

Background: The effects of GH deficiency (GHD) and GH replacement therapy (GHRT) on body composition and functional measures of physical fitness are largely unknown particularly in children.Study aim: To evaluate body composition, muscular strength and flexibility, and exercise tolerance in GHD children at baseline and after one-year GHRT.Patients and methods: We enrolled 19 children and adolescents with untreated ...

hrp0084p3-817 | Endocrine Oncology | ESPE2015

Two Synchronous Central Nervous System Tumors in a Child with Neurofibromatosis Type 1

Cornean Rodica Elena , Scutariu Monica , Ungureanu Gheorghe , Farcau Dorin , Florian Stefan

Background: Synchronous, multiple central nervous system (CNS) tumors are usually rare in pediatric patients. Pilocytic astrocytomas are the major type of CNS tumors in neurofibromatosis type 1 (NF1).Case presentation: A 6.5-year-old boy was admitted to our hospital for severe emaciation. Profound fat and muscle wasting were the only prominent clinical features. His growth rate was preserved despite his rapid dramatic weight loss (HT: 118 cm, P....